YDR131C Antibody

What is YDR131C and why are antibodies against it important in research?

YDR131C is the systematic name for the LAG2 gene in Saccharomyces cerevisiae, which encodes a longevity protein that interacts with the SCF (Skp1-Cullin-F-box) complex. Lag2 functions as an inhibitor of Rub1 (related to ubiquitin) conjugation to Cdc53 (cullin), a modification that regulates SCF complex activity .

Antibodies against YDR131C/Lag2 are essential research tools because:

• They enable detection and quantification of Lag2 protein in various experimental contexts

• They facilitate the study of protein-protein interactions involving Lag2

• They help investigate the regulatory mechanisms of the SCF complex

• They support research on longevity and aging pathways where Lag2 plays a role

What experimental systems are most suitable for studying YDR131C/Lag2 antibody interactions?

The most suitable experimental systems include:

• Yeast cell cultures: Wild-type and various mutant strains (lag2Δ, dcn1Δ, rub1Δ, and combination mutants) cultured in YPD medium and harvested during exponential growth phase

• In vitro systems: Reconstituted systems using recombinant proteins expressed in E. coli BL21 (DE3) or insect cells (Sf21)

• Immobilized protein complexes: Ni²⁺-agarose bead-immobilized protein complexes for binding studies

These systems allow researchers to investigate Lag2's role in protein modification pathways and its interaction with SCF components under controlled conditions.

What are the recommended protocols for Lag2 antibody-based protein detection?

For optimal Lag2 antibody-based protein detection:

• Cell lysis:

  • Harvest yeast cells in exponential growth phase

  • Lyse cells with glass beads and a multibeads shocker in buffer containing:

    • 40 mM Tris-HCl (pH 7.5)

    • 60 mM NaCl

    • 1 mM dithiothreitol

    • 0.2% Triton X-100

    • Protease inhibitors (5 μg/ml each of leupeptin, antipain, pepstatin A, and aprotinin)

• Immunoblot analysis:

  • Separate proteins by SDS-PAGE

  • Transfer to appropriate membrane

  • Block and probe with anti-Lag2 antibody

  • Visualize using appropriate secondary antibody and detection system

• Immunoprecipitation:

  • Prepare cell lysates as described above

  • Incubate with anti-Lag2 antibody

  • Capture complexes using protein A/G beads

  • Wash with buffer containing 40 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM dithiothreitol, and 0.5% Triton X-100

  • Elute and analyze by immunoblotting

What controls should be included in YDR131C/Lag2 antibody experiments?

To ensure experimental validity when working with YDR131C/Lag2 antibodies, include these controls:

How can I design experiments to study Lag2's inhibition of Rub1 conjugation to Cdc53?

To study Lag2's inhibition of Rub1 conjugation to Cdc53, consider this experimental approach:

• Prepare yeast strains:

  • Wild-type strain

  • rub1Δ single mutant

  • rub1Δ lag2Δ double mutant

  • rub1Δ dcn1Δ double mutant

  • rub1Δ lag2Δ dcn1Δ triple mutant

• In vitro Rub1 conjugation assay:

  • Prepare cell lysates from each strain

  • Use endogenous Cdc53 as substrate and endogenous Ubc12 as E2

  • Add recombinant components:

    • His₆-tagged Ula1

    • His₆-tagged Uba3

    • His₆-tagged Rub1

  • Incubate with ATP

  • Detect rubylated Cdc53 by immunoblotting

• Comparative analysis:

  • Quantify Cdc53 rubylation levels across strains

  • Compare rubylation efficiency in the presence/absence of recombinant His₆-Lag2

  • Assess dose-dependent effects by titrating His₆-Lag2 concentrations

• Growth phenotype assessment:

  • Measure growth rates of strains in YPD medium

  • Plot growth curves and calculate doubling times

  • Correlate growth phenotypes with Cdc53 rubylation status

This design allows for comprehensive analysis of Lag2's inhibitory role and its biological significance.

What approaches can resolve contradictory results when studying YDR131C/Lag2 function?

When facing contradictory results in YDR131C/Lag2 functional studies, consider these approaches:

• Genetic validation:

  • Create independent knockout strains using different marker systems

  • Complement lag2Δ strains with plasmid-expressed Lag2 to verify phenotype rescue

  • Use CRISPR-Cas9 to introduce point mutations in functional domains

• Biochemical validation:

  • Employ multiple antibodies targeting different Lag2 epitopes

  • Use tagged versions (e.g., His₆-Lag2) alongside native protein studies

  • Validate protein-protein interactions through reciprocal co-immunoprecipitation

• Experimental condition assessment:

  • Test different growth phases (log vs. stationary)

  • Vary media conditions (rich vs. synthetic)

  • Compare results across different strain backgrounds

• Multi-method approach:

  • Combine genetic, biochemical, and cell biological methods

  • Corroborate in vitro findings with in vivo experiments

  • Use quantitative methods (RT-PCR, quantitative immunoblotting) alongside qualitative assays

How can I optimize co-immunoprecipitation experiments to identify novel Lag2 binding partners?

To optimize co-immunoprecipitation for novel Lag2 binding partner identification:

• Sample preparation:

  • Harvest cells in exponential phase to capture active complexes

  • Use gentle lysis conditions to preserve weaker interactions:

    • 40 mM Tris-HCl (pH 7.5)

    • 60 mM NaCl

    • 1 mM dithiothreitol

    • 0.2% Triton X-100

    • Protease inhibitor cocktail

• Immunoprecipitation strategies:

  • Direct approach: Use anti-Lag2 antibodies conjugated to beads

  • Tagged approach: Express His₆-Lag2 and use Ni²⁺-agarose affinity capture

  • Cross-linking approach: Stabilize transient interactions with DSP or formaldehyde

• Washing optimization:

  • Titrate salt concentration (60-150 mM NaCl) to balance specificity and sensitivity

  • Adjust detergent concentration (0.2-0.5% Triton X-100) based on interaction strength

  • Consider including protein stabilizers (glycerol, BSA) for weaker interactions

• Analysis methods:

  • Mass spectrometry for unbiased partner identification

  • Sequential immunoblotting for candidate approach

  • Comparison between wild-type and mutant conditions to identify specific interactions

What are the best methods to study the functional relationship between Lag2 and SCF complex activity?

To investigate the functional relationship between Lag2 and SCF complex activity:

• In vitro SCF activity assays:

  • Reconstitute SCF complex with Cdc53/His₆-Rbx1 expressed in Sf21 cells

  • Add purified F-box proteins and Skp1

  • Use phosphorylated Sic1 as substrate (phosphorylated by Cln2-Cdc28 complex)

  • Test SCF activity with and without His₆-Lag2

  • Measure substrate ubiquitination efficiency

• Structure-function analysis:

  • Generate Lag2 truncation and point mutants

  • Test each variant's ability to:

    • Bind to Cdc53/Rbx1

    • Inhibit Rub1 conjugation

    • Affect SCF-mediated substrate ubiquitination

• Competitive binding studies:

  • Immobilize Cdc53/His₆-Rbx1 complex on Ni²⁺-agarose beads

  • Add varying concentrations of His₆-Lag2

  • Assess displacement of other SCF components or regulatory factors

  • Quantify binding affinities through biochemical techniques

• Substrate degradation kinetics:

  • Track degradation of known SCF substrates in vivo

  • Compare degradation rates between wild-type and lag2Δ strains

  • Correlate with Cdc53 rubylation status

How can YDR131C/Lag2 antibodies be utilized in high-throughput screening approaches?

For high-throughput screening using YDR131C/Lag2 antibodies:

• Antibody-based protein arrays:

  • Develop a Lag2-specific antibody suitable for array-based detection

  • Screen for interactions using protein library arrays

  • Validate hits using biophysics-informed computational models similar to those used for antibody specificity analysis

• Flow cytometry applications:

  • Adapt anti-Lag2 antibodies for intracellular staining

  • Design fluorescent reporters for Lag2 activity

  • Establish high-throughput sorting parameters for phenotypic screens

• Automated immunoassay platforms:

  • Develop electrochemiluminescence-based multiplex assays similar to those used for antibody binding studies

  • Optimize for detection of Lag2 and its modified forms

  • Incorporate machine learning algorithms for data interpretation

• Computational modeling integration:

  • Use experimental antibody selection data to train biophysics-informed models

  • Apply these models to predict antibody variants with desired specificity profiles

  • Validate computationally designed antibodies experimentally

This approach combines traditional antibody techniques with advanced computational methods to enhance throughput and predictive power in YDR131C/Lag2 research.

What are the key considerations when selecting between different antibody types for YDR131C/Lag2 research?

When selecting antibodies for YDR131C/Lag2 research, consider:

• Polyclonal vs. monoclonal antibodies:

  • Polyclonal advantages: Recognize multiple epitopes, higher sensitivity, robust to minor protein modifications

  • Monoclonal advantages: Consistent lot-to-lot performance, higher specificity, reduced background

• Species considerations:

  • Primary antibody species should differ from experimental system

  • Consider cross-reactivity with orthologs when studying conserved proteins

  • Evaluate secondary antibody compatibility

• Application-specific requirements:

  • Immunoblotting: Preferably antibodies recognizing denatured epitopes

  • Immunoprecipitation: Antibodies with high affinity for native conformation

  • Immunofluorescence: Low background, high signal-to-noise ratio

• Validation requirements:

  • Confirm specificity using lag2Δ mutant as negative control

  • Test recombinant His₆-Lag2 as positive control

  • Validate across multiple experimental conditions

How can I integrate computational approaches with experimental antibody data for YDR131C studies?

To integrate computational approaches with experimental antibody data:

• Binding mode analysis:

  • Apply biophysics-informed models to identify different binding modes

  • Disentangle modes associated with specific ligands or epitopes

  • Use this information to predict antibody variants with customized specificity profiles

• Structure-guided epitope mapping:

  • Use computational modeling to predict Lag2 protein structure

  • Identify surface-exposed regions likely to be immunogenic

  • Design epitope-specific antibodies targeting functional domains

• Library design and screening:

  • Apply computational approaches to design minimal antibody libraries

  • Focus on CDR3 variations as done in antibody development studies

  • Use high-throughput sequencing to analyze selection results

• Data analysis integration:

  • Apply R packages like data.table for efficient analysis of large-scale antibody selection data

  • Implement groupingsets functions for multidimensional analysis across experimental conditions

  • Develop predictive models that combine binding data with functional outcomes

This integrated approach enhances the power of traditional antibody-based methods with computational prediction and analysis.

What are common issues with YDR131C/Lag2 antibody experiments and how can they be resolved?

How can I validate the specificity of custom-generated YDR131C/Lag2 antibodies?

To validate custom-generated YDR131C/Lag2 antibodies:

• Genetic validation:

  • Test antibody against wild-type and lag2Δ strains

  • The absence of signal in lag2Δ confirms specificity

• Biochemical validation:

  • Use recombinant His₆-Lag2 as positive control

  • Perform peptide competition assays with immunizing peptide

  • Test against related proteins to assess cross-reactivity

• Multi-technique confirmation:

  • Validate across multiple applications (immunoblotting, immunoprecipitation)

  • Confirm localization patterns match known Lag2 distribution

  • Compare results with commercial antibodies if available

• Epitope mapping:

  • Identify the specific epitope recognized by the antibody

  • Use truncation mutants to narrow down binding region

  • Apply computational approaches similar to those used in antibody specificity studies